An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing
Ordered, the House concurring, that when the Senate and House adjourn, they do so until Tuesday, May 2, 2023, at 10:00 in the morning, or until the call of the President of the Senate and the Speaker of the House, respectively.